KENNEDY LEWIS MANAGEMENT LP
KENNEDY LEWIS MANAGEMENT LP's purchase track record
How the stock did after each of KENNEDY LEWIS MANAGEMENT LP's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/2/2022 | RPID | $284K | -34.5% | -68.0% | -2.4% |
| 5/25/2022 | RPID | $563K | -24.1% | -49.9% | +1.2% |
| 5/17/2022 | RPID | $394K | -17.6% | -39.1% | -2.4% |
| 3/18/2022 | KODK | $15.48M | -13.7% | -15.9% | -13.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
KODK: No new company-specific news in the last 7 days. The only recent article mentioning Eastman KODK is a historical anecdote about Warren Buffett's early investments, which does not reflect current company operations or financial results. There are no new earnings reports, product launches, or strategic updates for the stock in this period. The technical snapshot shows the stock trading near support levels, but without fresh news, the focus remains on existing market conditions.
Transaction History
| RPID | ▲ Buy | Open Market | 20,602 | $96K | 6/3/2022 | View on chart |
| RPID | ▲ Buy | Open Market | 29,398 | $137K | 6/3/2022 | View on chart |
| RPID | ▲ Buy | Open Market | 4,162 | $21K | 6/2/2022 | View on chart |
| RPID | ▲ Buy | Open Market | 5,938 | $30K | 6/2/2022 | View on chart |
| RPID | ▲ Buy | Open Market | 19,414 | $92K | 6/1/2022 | View on chart |
| RPID | ▲ Buy | Open Market | 27,703 | $132K | 6/1/2022 | View on chart |
| RPID | ▲ Buy | Open Market | 8,241 | $42K | 5/31/2022 | View on chart |
| RPID | ▲ Buy | Open Market | 11,759 | $60K | 5/31/2022 | View on chart |
| RPID | ▲ Buy | Open Market | 618 | $3K | 5/27/2022 | View on chart |
| RPID | ▲ Buy | Open Market | 882 | $5K | 5/27/2022 | View on chart |
| RPID | ▲ Buy | Open Market | 8,687 | $43K | 5/26/2022 | View on chart |
| RPID | ▲ Buy | Open Market | 12,396 | $61K | 5/26/2022 | View on chart |
| RPID | ▲ Buy | Open Market | 16,933 | $74K | 5/25/2022 | View on chart |
| RPID | ▲ Buy | Open Market | 11,867 | $52K | 5/25/2022 | View on chart |
| RPID | ▲ Buy | Open Market | 11,125 | $44K | 5/18/2022 | View on chart |
| RPID | ▲ Buy | Open Market | 15,875 | $63K | 5/18/2022 | View on chart |
| RPID | ▲ Buy | Open Market | 40,873 | $169K | 5/17/2022 | View on chart |
| RPID | ▲ Buy | Open Market | 28,643 | $118K | 5/17/2022 | View on chart |
| KODK | ▲ Buy | Option Exercise | 10,000 | — | 5/17/2022 | View on chart |
| KODK | ▲ Buy | Option Exercise | 10,000 | — | 5/17/2022 | View on chart |
| KODK | ▲ Buy | Open Market | 137,763 | $838K | 3/21/2022 | View on chart |
| KODK | ▲ Buy | Open Market | 9,636 | $60K | 3/21/2022 | View on chart |
| KODK | ▲ Buy | Open Market | 6,752 | $42K | 3/21/2022 | View on chart |
| KODK | ▲ Buy | Open Market | 96,542 | $587K | 3/21/2022 | View on chart |
| KODK | ▲ Buy | Open Market | 781,365 | $4.7M | 3/18/2022 | View on chart |
| KODK | ▲ Buy | Open Market | 547,571 | $3.3M | 3/18/2022 | View on chart |
| KODK | ▲ Buy | Open Market | 352,392 | $1.8M | 3/18/2022 | View on chart |
| KODK | ▲ Buy | Open Market | 502,851 | $2.5M | 3/18/2022 | View on chart |
| KODK | ▲ Buy | Open Market | 103,009 | $636K | 3/18/2022 | View on chart |
| KODK | ▲ Buy | Open Market | 146,991 | $908K | 3/18/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
RPID Presents at Small-Cap Virtual Conference
Rapid Micro Biosystems presented at a small‑cap virtual conference, sharing updates on its product pipeline and business strategy. The event offered investors a chance to hear directly from management about recent progress and future plans. The presentation follows the company’s recent trading activity, with an RSI of 31.3 and support near $1.66.
RPID Presents at Small-Cap Virtual Conference. Rapid Micro Biosystems presented at a small‑cap virtual conference, sharing updates on its product pipeline and business strategy. The event offered investors a chance to hear directly from management about recent progress and future plans. The presentation follows the company’s recent trading activity, with an RSI of 31.3 and support near $1.66.